Summary
To investigate whether mdr1 gene products are involved in conferring the chemoresistant phenotype to human colorectal carcinomas (HCCs), we determined the mdr1 mRNA expression level (mdr1 EL) in surgical specimens from 29 pharmacologically untreated patients and analyzed the relationship between mdr1 EL and drug resistance in an in vitro experimental model. This consisted of 7 HCC cell lines chosen to cover the range of mdr1 ELs detected in the neoplastic specimens. No relationship was observed between the mdr1 EL of the HCC cell lines and the degree of chemosensitivity found for each drug tested, regardless of whether mdr1 gene products may [doxorubicin (DOX), vincristine (VCR), and actinomycin-D (ACTD)] or may not affect [cis-diamminedichloroplatinum (CDDP)] drug-transmembrane equilibria. Conversely, a direct relationship was found between the mdr1 EL of HCC cell lines and the number of drug-resistant (DR) colonies arising from each parent cell line treated in continuous culture with high DOX concentrations. In addition, the chemoresistance index and mdr1 EL of the DR cell variants were roughly proportional to the mdr1 EL of the parent cell line. Our findings suggest that primary HCCs derive multidrug resistance from biochemical mechanism(s) other than mdr1 gene products. However, the mdr1 EL might be indicative of a predisposition to develop DR cell variants after chemotherapeutic treatment.
Similar content being viewed by others
References
Alitalo K, Schwab M, Lin CC, Varmus H, Bishop JM (1983) Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci USA 80: 1707
Chan HSL, Thorner PS, Haddad G, Ling V (1990) Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8: 689
Chin JE, Soffir R, Noonan KE, Choi K, Roninson IB (1989) Structure and expression of the human MDR (P-glycoprotein) gene family. Mol Cell Biol 9: 3808
Cohen FM, Shank B, Friedman M (1989) Colorectal cancer. In: De Vita V, Hellman S, Rosenberg SA (eds) Cancer, principles and practice of oncology. J. B. Lippincott, Philadelphia, p 895
Cox RA (1968) The use of guanidine chloride in the isolation of nucleic acid. Methods Enzymol 12: 120
Dano K (1973) Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim Biophys Acta 323: 446
Galligioni E, Della Valentina M, Crivellari D, Lo Re G, Frustaci S, Tumolo S, Lestuzzi C, Pacciarini M, Monfardini S (1989) 4′-Deoxydoxorubicin (esorubicin) and verapamil in colorectal cancer. Invest New Drugs 7: 380
Gerlach JH, Kartner N, Bell DR, Ling V (1986) Multidrug resistance. Cancer Surv 5: 25–46
Goldie JH, Coldman AJ (1984) The origin of drug resistance in neoplasms: implications for systemic therapy. Cancer Res 44: 3643
Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pastan I (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81: 116
Klohs WD, Steinkampf RW (1988) Possible link between the intrinsic drug resistance of colon tumors and a detoxification mechanism of intestinal cells. Cancer Res 48: 3021
Ling V, Kartner N, Sudo T, Siminovich L, Riordan IR (1983) Multidrug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat Rep 67: 869
Lorico A, Toffoli G, Boiocchi M, Erba E, Broggini M, Rappa G, D'Incalci M (1988) Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid. Cancer Res 48: 2036
Maniatis T, Fritsch EF, Sambrook J (1982) Appendix A: biochemical techniques. In: Maniatis T, Fritsch EF, Sambrook J (eds) Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, p 436
Merkel DE, Fuqua SAW, Tandon AK, Hill SM, Buzdar AV, McGuire WL (1989) Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification. J Clin Oncol 7: 1129
Mizoguchi T, Yamada K, Furukawa T, Hidaka K, Hisatsugu T, Shimazu H, Tsuruo T, Sumizawa T, Akiyama S (1990) Expression of the MDR1 gene in human gastric and colorectal carcinomas. J Natl Cancer Inst 82: 1679
Moscow JA, Fairchild CR, Madden MJ, Ranson DT, Wieand HS, O'Brien EE, Poplack DG, Cossman J, Myers CE, Cowan KH (1989) Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res 49: 1422
Park JG, Kramer BS, Lai SL, Goldstein LJ, Gardar AE (1990) Chemosensitivity patterns and expression of human multidrug resistance-associated mdr1 gene by human gastric and colorectal carcinoma cell lines. J Natl Cancer Inst 82: 193
Ponte P, Gunning P, Blau H, Kedes L (1983) Human actin genes are single copy for α-skeletal and α-cardiac actin but multicopy for β- and γ-cytoskeletal genes: 3′ untranslated regions are isotype specific but are conserved in evolution. Mol Cell Biol 3: 1783
Riordan JR, Deuchase K, Kartner N, Alon N, Trent J, Ling V (1985) Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 316: 817
Salmon SE (1990) Chemosensitivity testing: another chapter. J Natl Cancer Inst 82: 82
Schneider J, Bak M, Efferth T, Kaufmann M, Mattern J, Volm M (1989) P-glycoprotein expression in treated and untreated human breast cancer. Br J Cancer 60: 815
Shen DW, Pastan I, Gottesman MM (1988) In situ hybridization analysis of acquisition and loss of the human multidrug-resistance gene. Cancer Res 48: 4334
Southern E (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503
Toffoli G, Bevilacqua C, Franceschini A, Boiocchi M (1989) In K562 cells treated with doxorubicin and hemin, a decrease in c-myc mRNA expression correlates with loss of self-renewal capability but not with erythroid differentiation. Leuk Res 13: 279
Ubezio P, Limonta M, D'Incalci M, Damia G, Masera G, Giudici G, Wolverto JS, Beck WT (1989) Failure to detect the P-glycoprotein multidrug resistant phenotype in cases of resistant childhood acute lymphocytic leukaemia. Eur J Cancer Clin Oncol 25: 1895
Author information
Authors and Affiliations
Additional information
Supported by grants from the Italian Association for Cancer Research, Milan, Italy, and by CNR Progetto Finalizzato “Oncologia” contract 88.00537.44
Rights and permissions
About this article
Cite this article
Toffoli, G., Viel, A., Tumiotto, L. et al. Expression of the mdr1 gene in human colorectal carcinomas: relationship with multidrug resistance inferred from analysis of human colorectal carcinoma cell lines. Cancer Chemother. Pharmacol. 29, 283–289 (1992). https://doi.org/10.1007/BF00685946
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00685946